Systems Biology Opens New Research Pathways
Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Blockbuster Drugs: Endangered Species?
Our list of top-selling drugs of the 21st century shows how much money those drugs made between 2000 and 2011; the total amounts for all of them are in the billions. However, given the advent of personalized medicine and the increasing number of biosimilars entering the market, will pharmaceutical giants be able to maintain that level of success, or does our list contain the last of the blockbusters?